SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000899243-19-007975
Filing Date
2019-03-15
Accepted
2019-03-15 16:39:21
Documents
1
Period of Report
2019-03-13

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 4981
  Complete submission text file 0000899243-19-007975.txt   6493
Mailing Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139
Business Address 955 MASSACHUSETTS AVENUE 4TH FLOOR CAMBRIDGE MA 02139 857-529-8300
X4 Pharmaceuticals, Inc (Issuer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ABPRO CORPORATION 65 CUMMINGS PARK DRIVE WOBURN MA 01801
Business Address
Mostafa Adam S. (Reporting) CIK: 0001738081 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38295 | Film No.: 19685539